Minimally Invasive And Non Invasive Product And Service Market Report 2026

Minimally Invasive And Non Invasive Product And Service Market Overview

• Minimally Invasive And Non Invasive Product And Service market size has reached to $148.77 billion in 2025 • Expected to grow to $216.48 billion in 2030 at a compound annual growth rate (CAGR) of 7.7% • Growth Driver: Elevated Incidence Of Chronic Diseases Fueling The Minimally Invasive And Non-Invasive Product And Service Market • Market Trend: Advanced Visualization Platforms Support Minimally Invasive Procedures • North America was the largest region in 2025.

What Is Covered Under Minimally Invasive And Non Invasive Product And Service Market?

Minimally invasive and non-invasive products and services refer to medical devices and therapeutics that don't enter the body, and such procedures do not use instruments that directly penetrate the body or breach the skin. These products and services are used to make several surgeries dramatically safer and more tolerable. The major types of minimally invasive and non-invasive products and services are surgical devices, electrosurgical devices, imaging devices, robotic systems, and others. Major technologies involved are non-visual imaging, transcatheter surgery, and laparoscopic surgery. These are used for several applications, such as cardio thoracic surgery, vascular surgery, neurological surgery, cosmetic surgery, gastrointestinal surgery, and dental surgery, and are used by many end-user industries, such as hospital surgical departments, outpatient surgical centers, group practices, individual surgeons, medical schools, and others.

What Is The Minimally Invasive And Non Invasive Product And Service Market Growth Forecast?

The minimally invasive and non invasive product and service market size is expected to see strong growth in the next few years. It will grow to $216.48 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to increasing demand for outpatient and day-care surgeries, rising adoption of robotic surgical platforms, expansion of precision medicine applications, growing focus on cost-effective surgical solutions, increasing integration of advanced imaging with surgical workflows. Major trends in the forecast period include increasing adoption of image-guided surgical systems, rising demand for robotic-assisted minimally invasive procedures, growing use of non-invasive diagnostic technologies, expansion of precision-control surgical instruments, enhanced focus on patient safety and faster recovery.

Global Minimally Invasive And Non Invasive Product And Service Market Segmentation

1) By Procedure Type: Minimally Invasive Procedures, Non-Invasive Procedures 2) By Product And Service Category: Diagnostic And Imaging Devices, Monitoring And Assessment Devices, Therapeutic And Treatment Devices, Robotic And Computer-Assisted Systems, Procedure-Supporting Services 3) By Technology Type: Imaging-Based Technologies, Energy-Based Technologies, Catheter-Free And Incision-Free Technologies, Robotic And Navigation-Assisted Technologies, Sensor-Based And Digital Health Technologies 4) By Application Area: Cardiovascular Care, Neurology And Brain Health, Gastrointestinal Care, Orthopedic And Musculoskeletal Care, Aesthetic And Cosmetic Care, Dental And Oral Care 5) By Care Setting: Hospitals, Ambulatory And Outpatient Care Centers, Specialty Clinics, Diagnostic And Imaging Centers, Home-Based And Remote Care Settings Subsegments: 1) By Minimally Invasive Procedures: Laparoscopic Procedures, Endoscopic Procedures, Catheter-Based Procedures, Robotic-Assisted Minimally Invasive Procedures, Image-Guided Minimally Invasive Procedures 2) By Non-Invasive Procedures: Imaging-Based Diagnostic Procedures, Energy-Based Therapeutic Procedures, Non-Contact Monitoring And Assessment Procedures, External Device-Based Therapeutic Procedures, Digital And Sensor-Based Diagnostic Procedures

What Is The Driver Of The Minimally Invasive And Non Invasive Product And Service Market?

The rise in chronic diseases is expected to propel the growth of the minimally invasive and non-invasive product and service market going forward. Chronic diseases are long-term medical conditions that persist over an extended period, typically three months or more. The market for minimally invasive and non-invasive products is poised for growth as patients with chronic conditions increasingly prefer treatments that offer reduced pain, shorter recovery times, and minimal disruption to daily life, given the versatility and effectiveness of these procedures in managing various chronic diseases. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the rise in chronic diseases will drive the growth of the minimally invasive and non-invasive product and service market.

Key Players In The Global Minimally Invasive And Non Invasive Product And Service Market

Major companies operating in the minimally invasive and non invasive product and service market are Medtronic Plc, Olympus Corporation, Smith & Nephew Plc, Stryker Corporation, Teleflex Incorporated, Boston Scientific Corporation, CONMED Corporation, Intuitive Surgical Inc., Fujifilm Holdings Corporation, Zimmer Biomet Holdings Inc., B. Braun Holding GmbH & Co. KG, HOYA Corporation, GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Integra LifeSciences Corporation, NuVasive Inc., Surgical Innovations Group Plc, Clarus Medical LLC, Alphatec Holdings Inc., CooperSurgical Inc., Abbott Laboratories, Terumo Medical Corporation, Johnson & Johnson Inc., AtriCure Inc.

Global Minimally Invasive And Non Invasive Product And Service Market Trends and Insights

Major companies operating in the minimally invasive and non-invasive products and services market are focusing on incorporating advanced visualization platforms such as integrated multi-mode imaging systems to enhance procedural accuracy, diagnostic precision, and workflow efficiency. Advanced visualization platforms are systems that combine multiple imaging modalities into a single interface, allowing clinicians to seamlessly switch between views and obtain comprehensive insight into the surgical or diagnostic field, enabling capabilities such as enhanced tissue visualization, real-time assessment, and improved clinical decision-making. For instance, in September 2025, Olympus, a Japan-based medical-technology company, launched the VISERA S OTV-S500 imaging platform, an advanced visualization platform designed to support ENT and urology procedures by integrating white-light imaging, Narrow Band Imaging (NBI), and stroboscopy into a unified system. It features high-quality image and video capture, modality switching for minimally invasive evaluation, and enhanced visualization for early disease detection. VISERA S OTV-S500 improves minimally invasive procedural performance, diagnostic confidence, and documentation efficiency.

What Are Latest Mergers And Acquisitions In The Minimally Invasive And Non Invasive Product And Service Market?

In July 2024, Merit Medical Systems Inc., a US-based provider of diagnostic and therapeutic medical devices for interventional cardiology, radiology, and endoscopy, acquired the assets of EndoGastric Solutions Inc. for approximately USD 105 million. With this acquisition, Merit Medical gains access to EndoGastric Solutions’ EsophyX Z+ technology and related intellectual property, thereby enhancing its minimally invasive gastrointestinal treatment capabilities while improving its market reach and product portfolio within GI endoscopy. EndoGastric Solutions Inc. is a US-based medical technology company specializing in incisionless devices for treating gastroesophageal reflux disease (GERD), is known for its EsophyX system used in the transoral incisionless fundoplication (TIF) procedure, a recognized minimally invasive therapy for chronic GERD.

Regional Outlook

North America was the largest region in the minimally invasive and non invasive product and service market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Minimally Invasive And Non Invasive Product And Service Market?

The minimally invasive and non invasive product and service market consists of revenues earned by entities by providing medical services such as X-rays, a standard eye exam, CT (computed tomography) scan, MRI (magnetic resonance imaging), ECG (electrocardiogram), and Holter monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The minimally invasive and non invasive product and service market also includes sales of catheter shafts, specialty needles, and subassemblies which are used in providing minimally invasive and non invasive services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.